Dergiler / Turkish journal of nephrology (Online) / 2021 / Cilt: 30 - Sayı: 1

Immune Tolerance in Transplant Kidney

Sayfa
86–89
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The absence of a clinical rejection in the follow-up of our case, which cannot be counted in the low-risk group in terms of rejection, reveals the importance of immune tolerance in maintaining allograft functions.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Immune tolerance in transplantation is the successful preservation of the allograft throughout the recipient’s lifetime.
📊
Temel Bulgular & Veri:Cadaveric renal transplantation was performed on the 65-year-old patient after an 18-hour cold ischemia period.
💡
Sonuç & Katkı:The absence of a clinical rejection in the follow-up of our case, which cannot be counted in the low-risk group in terms of rejection, reveals the importance of immune tolerance in maintaining allograft functions.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Immune tolerance in transplantation is the successful preservation of the allograft throughout the recipient’s lifetime. Cases with immunotolerance are of great importance in understanding the immune tolerance process and for possible innovations in the diagnosis and treatment processes. We aimed to present a patient who underwent renal transplantation from a cadaveric donor and revealed immunosuppressive withdrawal after two years of the transplantation. Cadaveric renal transplantation was performed on the 65-year-old patient after an 18-hour cold ischemia period. A 3/6 haplotype match and negative panel reactive antibody results were detected for both class I and class II antigens. The patient was discharged on post-operative day 13. Non-compliance was detected in the post-operative 29th month, and a renal biopsy was performed in the 56th month. Histo logical findings were nonspecific. The patient still lives with normal allograft functions. The absence of a clinical rejection in the follow-up of our case, which cannot be counted in the low-risk group in terms of rejection, reveals the importance of immune tolerance in maintaining allograft functions.

🔖

Bu Makaleye Atıf Yap

BOZACI, İ., TATAR, E., USLU, A., TAŞLI, F. (2021). Immune Tolerance in Transplant Kidney. Turkish journal of nephrology (Online), Cilt: 30 - Sayı: 1, 86–89. https://ajindex.com/articles/374937

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Newell KA, Adams AB, Laurence AT. Biomarkers of operational tolerance following kidney transplantation - The immune tolerance network studies of spontaneously tolerant kidney transplant recipients. Hum Immunol 2018; 79: 380-87. [Crossref] 2. Sarwal MM. Fingerprints of transplant tolerance suggest opportunities for immunosuppression minimization. Clin Biochem 2016; 49: 404-10. [Crossref] 3. Massart A, Pallier A, Pascual J, Viklicky O, Budde K, Spasovski G, et al. The DESCARTES-Nantes survey of kidney transplant recipients displaying clinical operational tolerance identifies 35 new tolerant patients and 34 almost tolerant patients. Nephrol Dial Transplant 2016; 31: 1002-13. [Crossref] 4. Baron D, Giral M, Brouard S. Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomes. Transpl Int 2015; 28: 938- 59. [Crossref] 5. Owens ML, Maxwell JG, Goodnight J, Wolcott MW. Discontinuance of immunosuppression in renal transplant patients. Arch Surg 1975; 110: 1450-1. [Crossref] 6. Zeng Y, Liu Z, Liu Y, Fan Y, Guo Y, Qiu J. Impact of HLA antibodies on graft survival in long-term renal recipients with functional grafts. Urol Int 2014; 92: 328-33. [Crossref] 7. Hricik DE, Formica RN, P, Nickerson P, Rush D, Fairchild RL, Poggio ED, et al. Adverse outcomes of tacrolimus withdrawal in immune-quiescent kidney transplant recipients. J Am Soc Nephrol 2015; 26: 3114-22. [Crossref] 8. Dugast E, Soulillou JP, Foucher Y, Papuchon E, Guerif P, Paul C, et al. Failure of calcineurin inhibitor (Tacrolimus) weaning randomized trial in long-term stable kidney transplant recipients. Am J Transplant 2016; 16: 3255-61. [Crossref] 9. Schmitz R, Fitch ZW, Schroder PM, Choi AY, Jackson AM, Knechtle SJ, et al. B cells in transplant tolerance and rejection: Friends or foes? Transpl Int 2020; 33: 30-40. [Crossref] 10. Tebbe B, Wilde B, Ye Z, Wang J, Wang X, Jian Fu, et al. Renal transplant recipients treated with calcineurin-inhibitors lack circulating immature transitional CD19+CD24hiCD38hi regulatory B lymphocytes. PLoS One 2016; 11: e0153170. [Crossref] 11. Thaunat O, Koenig A, Leibler C, Grimbert P. Effect of immunosuppressive drugs on humoral allosensitization after kidney transplant. J Am Soc Nephrol 2016; 27: 1890-900. [Crossref] 12. Kesiraju S, Ch UM, Paritala P, Reddy S, Reddy VS, Sahariah S. Unexplained post-renal transplant tolerance: A case report. Immunol Res 2016; 64: 791-94. [Crossref]